167
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Emergence of blaCTX-M-15, blaTEM-169 and blaPER-1 extended-spectrum β-lactamase genes among different Salmonella enterica serovars from human faecal samples

, , , , , , & show all
Pages 550-556 | Received 03 Jul 2015, Accepted 09 Mar 2016, Published online: 27 Apr 2016

References

  • Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis. 2003;16:467–472.
  • Angulo FJ, Johnson KR, Tauxe RV, et al. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist. 2000;6:77–3.
  • Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–951.
  • Chiappini EL, Galli L, Pecile P, et al. Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea. Clin Ther. 2002;24:1585–1594.
  • Al-Zahrani A, Akhtar N. Susceptibility patterns of extended spectrum ß_Lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital. Pakistan J Med Res. 2005;44:63–67.
  • Gniadkowsk M. Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect. 2001;7:597–608.
  • Rahal JJ. Extended-spectrum β-lactamases: how big is the problem? Clin Microbiol Infect. 2000;6:2–6.
  • Dhara L, Tripathi A, Pal A. Molecular characterization and in silico analysis of naturally occurring TEM beta-lactamase variants among pathogenic Enterobacteriaceae infecting Indian patients. Biomed Res Int 2013;2013:783540.
  • Hanson ND, Moland ES, Pitout JDD. Enzymatic characterization of TEM-63, a TEM-type extended spectrum β-lactamase expressed in three different genera of Enterobacteriaceae from South Africa. Diagn Microbiol Infect Dis. 2001;40:199–201.
  • Karunakaran R, Tay ST, Rahim FF, et al. Ceftriaxone resistance and genes encoding extended-spectrum β-lactamase among non-typhoidal Salmonella species from a tertiary care hospital in Kuala Lumpur, Malaysia. Jpn J Infect Dis. 2012;65:433–435.
  • Pardos de la Gándara M, Seral C, Castillo García J, et al. Prevalence and characterization of extended-spectrum beta-lactamases-producing Salmonella enterica isolates in Saragossa, Spain (2001–2008). Microb Drug Resist. 2011;17:207–213.
  • Liebana E, Batchelor M, Hopkins KL, et al. Resistance to oxyiminocephalosporins mediated by blaTEM-52 genes in Salmonella typhimurium from humans in England and Wales. Foodborne Pathog Dis. 2005;2:361–364.
  • Yong D, Lim YS, Yum JH, et al. Nosocomial outbreak of pediatric gastroenteritis caused by CTX-M-14-Type extended-spectrum β-Lactamase-producing strains of Salmonella enterica serovar London. J Clin Microbiol. 2005;43:3519–3521.
  • Miriagou V, Tassios PT, Legakis NJ, et al. Expanded- spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents. 2004;23:547–555.
  • Queenan AM, Foleno B, Gownley C, et al. Effects of inoculum and _beta lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol. 2004;42:269–275.
  • Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005;352:380–391.
  • Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother. 2002;50:1031–1034.
  • Robin F, Delmas J, Schweitzer C, et al. Evolution of TEM-Type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient. Antimicrob Agents Chemother. 2007;51:1304–1309.
  • Paterson DL, Bonomo RA. Extended-Spectrum β-Lactamases: a Clinical Update. Clin Microbiol. 2005;18:657–686.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23. Wayne, PA: CLSI; 2013. p. 33.
  • Neu HC, Heppel LA. The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts. J Biol Chem. 1965;240:3685–3692.
  • Edwards R, Hawkyard CV, Garvey MT, et al. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. J Antimicrob Chemother. 1999;43:273–276.
  • Sykes RB, Nordstrom K. Microiodometric determination of beta Lactamase activity. Antimicrob Agents Chemother. 1972;1:94–99.
  • Colowick SP, Kaplan, NO. Methods in enzymology. 1st ed. New York: Academic Press; 1955.
  • Matthew M, Harris AM, Marshall MJ, et al. The use of analytical isoelectric focusing for detection and identification of β-Lactamases. J General Microbiology. 1975;88:69–78.
  • Hamidian M, Tajbakhsh M, Walther-Rasmussen J, et al. Emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis. 2009;62:368–371.
  • Schlesinger J, Navon-Venezia S, Chmelnitsky I, et al. Extended-Spectrum Beta-Lactamases among enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob Agents Chemother. 2005;49:1150–1156.
  • Libisch B, Poirel L, Lepsanovic Z, et al. Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol Med Microbiol. 2008;54:330–338.
  • Sambrook J, Russell DW. Molecular CLONING: A LABORATORY manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001. p. 32–34.
  • Seidman CE, Struhl K, Sheen J, et al. Introduction of Plasmid DNA into Cells. Curr Protoc Mol Biol. 2001;Chapter 1:Unit1.8.
  • Soler P, González-Sanz R, Bleda MJ, et al. Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001–2003. J Antimicrob Chemother. 2006;58:310–314.
  • Ranjbar R, Giammanco GM, Farshad S, et al. Serotypes, antibiotic resistance, and class 1 integrons in Salmonella isolates from pediatric cases of enteritis in Tehran, Iran. Foodborne Pathog Dis. 2011;8:547–553.
  • Bonalli M, Stephan R, Käppeli U, et al. Salmonella enterica serotype Virchow associated with human infections in Switzerland: 2004–2009. BMC Infect Dis. 2011;11:49.
  • Sjölund-Karlsson M, Howie R, Krueger A, et al. CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States. Emerg Infect Dis. 2001;17:97–99.
  • Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect. 2008;14:33–41.
  • Su LH, Chiu CH, Chu C, et al. In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype Anatum. Antimicrob Agents Chemother. 2003;47:563–567.
  • Chanal C, Bonnet R, De Champs C, et al. Prevalence of β-Lactamases among 1,072 Clinical Strains of Proteus mirabilis: a 2-Year Survey in a French Hospital. Antimicrob Agents Chemother. 2000;44:1930–1935.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.